Recent Quarter Total Invested
$1.68 M
Recent Quarter Institutional Ownership Percentage
6.42%
Total Invested of Last Quarter
$2.54 M
Ownership Percentage of Last Quarter
6.68%
ImmunoPrecise Antibodies Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | 07/31/2024 | 1.30 M | $1.31 M | 0.54% | 5.02% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 63,910 | $64,549 | 69.97% | 0.25% |
| BANK OF MONTREAL /CAN/ | 08/14/2024 | 55,857 | $61,443 | 3.81% | 0.22% |
| NORTHERN TRUST CORP | 08/14/2024 | 50,730 | $51,238 | -5.97% | 0.20% |
| CIBC WORLD MARKET INC. | 08/07/2024 | 41,200 | $42,000 | 0.00% | 0.16% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2024 | 27,033 | $27,303 | 22.69% | 0.10% |
| GRADIENT CAPITAL ADVISORS, LLC | 07/22/2024 | 26,808 | $27,076 | 0.00% | 0.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 17,484 | $17,658 | 0.00% | 0.07% |
| CITADEL ADVISORS LLC | 08/14/2024 | 14,100 | $14,241 | -13.50% | 0.05% |
| RATHBONES GROUP PLC | 08/09/2024 | 14,000 | $14,140 | 0.00% | 0.05% |
| XTX TOPCO LTD | 08/12/2024 | 12,695 | $12,822 | 100.00% | 0.05% |
| UBS GROUP AG | 08/14/2024 | 12,232 | $12,354 | 393.62% | 0.05% |
| MORGAN STANLEY | 08/14/2024 | 10,533 | $10,638 | 0.00% | 0.04% |
| MARINER, LLC | 08/13/2024 | 10,000 | $10,100 | 0.00% | 0.04% |
| SIMPLEX TRADING, LLC | 07/25/2024 | 7,648 | $7,000 | 661.75% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 6,900 | $6,969 | -33.01% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 5,084 | $5,135 | 100.00% | 0.02% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 2,408 | $2,432 | -36.28% | 0.01% |
| WEST PACES ADVISORS INC. | 07/17/2024 | 1,665 | $1,682 | 0.00% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 08/02/2024 | 1,540 | $1,472 | 0.00% | 0.01% |
| CITIGROUP INC | 08/12/2024 | 7 | $7 | 0.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| WOLVERINE TRADING, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
ImmunoPrecise Antibodies Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IPA shares?
During the previous two years, 25 institutional investors and hedge funds held shares of ImmunoPrecise Antibodies Ltd.. The most heavily invested institutionals were:
INGALLS & SNYDER LLC: 1.3 M
RENAISSANCE TECHNOLOGIES LLC: 63,910
BANK OF MONTREAL /CAN/: 55,857
NORTHERN TRUST CORP: 50,730
CIBC WORLD MARKET INC.: 41,200
Federation des caisses Desjardins du Quebec: 27,033
-
What percentage of ImmunoPrecise Antibodies Ltd. stock is owned by institutional investors?
6.42% of ImmunoPrecise Antibodies Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at IPA ?
Institutional investors have bought a total of 1.68 M shares in the last 24 months. This purchase volume represents approximately $1.02 M in transactions.